Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.77% is 38% below its 5-year average of 7.70%, near the low end of its 5-year range (0.51%–14.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 47.70% below its 12-month average of 9.11%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.77%.
DEBT TO ASSETS RATIO
4.77%
DEBT TO ASSETS RATIO AVG TTM
9.11%
DEBT TO ASSETS RATIO AVG 3Y
9.89%
DEBT TO ASSETS RATIO AVG 5Y
7.70%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-47.70%
CURRENT VS 3Y AVG
-51.80%
CURRENT VS 5Y AVG
-38.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 824 covered companies
CURRENT VS SECTOR MEDIAN
+5196.25%
vs the sector median at left
Aura Biosciences, Inc.
Market Cap
$631.47M
Debt to Assets Ratio
4.77%
TTM Avg
9.11%
3Y Avg
9.89%
5Y Avg
7.70%
Market Cap
$632.99M
Debt to Assets Ratio
0.31%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$621.58M
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$655.89M
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$661.98M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$664.67M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | $631.47M | 4.77% | 9.11% | 9.89% | 7.70% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $632.99M | 0.31% | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $638.60M | 0.07% | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $621.58M | 0.45% | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $621.02M | 0.01% | N/A | N/A | N/A |
| Starling Oncology, Inc. (STLN)vs › | $655.89M | 0.59% | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $661.98M | 0.08% | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $664.67M | 0.01% | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $669.30M | 0.10% | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 1.39% | N/A | N/A | N/A |
Debt/Assets
4.8%
Debt/Equity
0.05
Current Ratio
16.82
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 4.77% |
| 2026-03-31 | 12.34% |
| 2025-12-31 | 10.26% |
| 2025-09-30 | 9.34% |
| 2025-06-30 | 8.86% |
| 2025-03-31 | 11.87% |
| 2024-12-31 | 10.28% |
| 2024-09-30 | 9.29% |
| 2024-06-30 | 8.72% |
| 2024-03-31 | 8.22% |
| 2023-12-31 | 7.67% |
| 2023-09-30 | 11.23% |
| 2023-06-30 | 10.59% |
| 2023-03-31 | 10.02% |
| 2022-12-31 | 9.31% |
| 2022-09-30 | 14.72% |
| 2022-06-30 | 0.51% |
| 2022-03-31 | 0.57% |
| 2021-12-31 | 0.61% |
| 2021-09-30 | 1.23% |
| 2021-06-30 | 1.28% |
| 2021-03-31 | 0.82% |
| 2020-12-31 | 0.07% |
